Date | Time | Source | Headline | Symbol | Company |
05/17/2024 | 3:00PM | iHub Newswire | FeaturedMusic Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements | | |
04/23/2024 | 1:27AM | Alliance News | Moderna, Pfizer/BioNTech set for UK court clash over Covid jab patents | LSE:0A45 | Moderna Inc |
03/26/2024 | 7:00AM | RNS Non-Regulatory | Moderna Inc Moderna Achieves Positive Interim Results in Trial | LSE:0A45 | Moderna Inc |
12/15/2023 | 3:41AM | Alliance News | Merck gets US FDA nod for Welireg, as trial with Moderna bears fruit | LSE:0A45 | Moderna Inc |
12/14/2023 | 6:45AM | Alliance News | Moderna CEO Bancel says melanoma vaccine could be available by 2025 | LSE:0A45 | Moderna Inc |
12/11/2023 | 12:56PM | Alliance News | Merck reports mixed updates for cancer treatment, Keytruda | LSE:0A45 | Moderna Inc |
12/07/2023 | 7:00AM | RNS Non-Regulatory | Moderna Inc Moderna Reviews Progress at ESG Investor Event | LSE:0A45 | Moderna Inc |
10/30/2023 | 3:00AM | RNS Non-Regulatory | Moderna Inc CEPI & Moderna Harness MRNA to Advance Mission | LSE:0A45 | Moderna Inc |
09/14/2023 | 10:16AM | RNS Non-Regulatory | Moderna Inc EMA Adopts Positive Opinion of Covid-19 Vaccine | LSE:0A45 | Moderna Inc |
09/12/2023 | 3:04AM | Alliance News | US FDA approves updated Covid vaccines from Pfizer and Moderna | LSE:0A45 | Moderna Inc |
07/05/2023 | 8:27AM | Alliance News | Moderna submits global regulatory submission for respiratory vaccine | LSE:0A45 | Moderna Inc |
07/05/2023 | 7:00AM | RNS Non-Regulatory | Moderna Inc Moderna Announces Global Regulatory Submissions | LSE:0A45 | Moderna Inc |
07/03/2023 | 2:00AM | RNS Non-Regulatory | Moderna Inc Moderna Submits Filing to EMA for COVID-19 Vaccine | LSE:0A45 | Moderna Inc |
04/11/2023 | 2:00AM | RNS Non-Regulatory | Moderna Inc MRNA Cancer Vaccine Update | LSE:0A45 | Moderna Inc |
03/30/2023 | 7:00AM | RNS Non-Regulatory | Moderna Inc Moderna Finalizes Agreement with Kenyan Government | LSE:0A45 | Moderna Inc |
02/16/2023 | 2:13PM | Alliance News | Moderna, Pfizer, BioNTech Covid jab patent dispute heads to 2024 trial | LSE:0A45 | Moderna Inc |
12/20/2022 | 7:51AM | RNS Non-Regulatory | Moderna Inc Chantal Friebertshäuser Joins Moderna | LSE:0A45 | Moderna Inc |
12/16/2022 | 7:36AM | RNS Non-Regulatory | Moderna Inc EMA Committee for Medicinal Products for Human Use | LSE:0A45 | Moderna Inc |
12/13/2022 | 7:00AM | RNS Non-Regulatory | Moderna Inc Moderna and Merck Announce mRNA Cancer Vaccine | LSE:0A45 | Moderna Inc |
10/19/2022 | 12:56PM | RNS Non-Regulatory | Moderna Inc EMA Recommends Authorization of Moderna Vaccine | LSE:0A45 | Moderna Inc |
10/19/2022 | 12:38PM | RNS Non-Regulatory | Moderna Inc EMA Issues Positive Opinion | LSE:0A45 | Moderna Inc |
10/12/2022 | 7:15AM | RNS Non-Regulatory | Moderna Inc Merck and Moderna Announce Exercise of Option | LSE:0A45 | Moderna Inc |
09/02/2022 | 12:58AM | Alliance News | US CDC recommends boosters targeting Omicron | LSE:0A45 | Moderna Inc |
08/26/2022 | 9:18AM | Alliance News | TOP NEWS: Moderna sues Pfizer, BioNTech for jab patent infringement | LSE:0A45 | Moderna Inc |
06/22/2022 | 2:00AM | RNS Non-Regulatory | Moderna Inc Moderna Plans to Bring mRNA Innovation to UK | LSE:0A45 | Moderna Inc |
06/17/2022 | 9:35AM | Alliance News | US approves Pfizer and Moderna vaccines for youngest children | LSE:0A45 | Moderna Inc |
02/24/2022 | 10:53AM | Alliance News | TOP NEWS: Moderna plans commercial expansion after annual profit surge | LSE:0A45 | Moderna Inc |
12/16/2021 | 3:55PM | Alliance News | US panel recommends Pfizer, Moderna Covid vaccines over J&J vaccine | LSE:0A45 | Moderna Inc |
11/30/2021 | 4:19AM | Alliance News | PRESS: Moderna CEO warns current vaccines may struggle against Omicron | LSE:0A45 | Moderna Inc |
11/19/2021 | 4:22PM | Alliance News | US authorizes Covid boosters for all adults, recommends for over-50s | LSE:0A45 | Moderna Inc |